Genus Capital Management’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$301K Sell
2,081
-80
-4% -$12.1K 0.03% 166
2025
Q4
$310K Hold
2,161
0.04% 169
2025
Q3
$332K Buy
2,161
+292
+16% +$45.6K 0.04% 173
2025
Q2
$298K Sell
1,869
-12,470
-87% -$2.04M 0.04% 159
2025
Q1
$2.44M Buy
+14,339
New +$2.4M 0.35% 81
2024
Q2
Sell
-2,956
Closed -$483K 338
2024
Q1
$480K Buy
+2,956
New +$464K 0.06% 159
2023
Q4
Sell
-18,985
Closed -$2.81M 329
2023
Q3
$2.77M Sell
18,985
-1,093
-5% -$167K 0.44% 75
2023
Q2
$3.05M Buy
+20,078
New +$3.03M 0.45% 73

Other funds holding PG

Genus Capital Management's PG Position: Q1 2026 in Review

Genus Capital Management reduced its Procter & Gamble (PG) stake by 3.7% in Q1 2026, selling an estimated $12.1K and leaving 2,081 shares worth $301K. The position accounts for 0.03% of the portfolio, ranked #166.

Genus Capital Management first reported a position in PG in Q2 2023 and has held it in 8 quarters since. The position peaked at $3.05M in Q2 2023. 3,984 funds tracked by Wall St. Rank hold PG as of Q1 2026.

  • Genus Capital Management held 2,081 shares of Procter & Gamble worth $301K as of Q1 2026.
  • Genus Capital Management sold 80 Procter & Gamble shares in Q1 2026, an estimated $12.1K.
  • Procter & Gamble made up 0.03% of Genus Capital Management's portfolio in Q1 2026, its #166 holding.
  • Genus Capital Management first reported a position in Procter & Gamble in Q2 2023 and has held it in 8 quarters since.
  • Genus Capital Management's Procter & Gamble position peaked at $3.05M in Q2 2023.
  • 3,984 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.

Based on Genus Capital Management's 13F filing for Q1 2026, filed 4 May 2026.